Finance

Lists
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
75,22 $
+0,82%
(+0,61) 1D
75,22 $
0,00% (0,00)
After hours
Closed: 1 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
73,87 $
High
76,11 $
Low
73,14 $
Mkt. cap
5,87 млрд
Avg. vol.
538,93 м.
Volume
878,56 м.
P/E ratio
76,53
52-wk high
82,94 $
52-wk low
35,20 $
EPS
0,98 $
Beta
0,09
Shares outstanding
48,29 млн
No. of employees
366
Open
73,87 $
High
76,11 $
Low
73,14 $
Mkt. cap
5,87 млрд
Avg. vol.
538,93 м.
Volume
878,56 м.
P/E ratio
76,53
52-wk high
82,94 $
52-wk low
35,20 $
EPS
0,98 $
Beta
0,09
Shares outstanding
48,29 млн
No. of employees
366
News stories
From web sources and news partners
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersЛондон, Англия, Ұлыбритания
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to KNSA in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current 75,22 $
107,00 $ (+42,25%)
Average
96,57 $ (+28,38%)
Lowest
87,00 $ (+15,66%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yanan Zhu
Wells Fargo
Buy
Maintained
87,00 $
+15,7%
09/29/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
98,00 $
+30,3%
08/12/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 $
+19,6%
07/30/2026
David Nierengarten
Wedbush
Buy
Reiterated
99,00 $
+31,6%
07/28/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
107,00 $
+42,2%
07/29/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
87,00 $
+15,7%
07/29/2026
Geoff Meacham
Citi
Buy
Maintained
100,00 $
+32,9%
07/29/2026
Nicholas Lorusso
TD Cowen
Buy
Maintained
95,00 $
+26,3%
07/28/2026
Roger Song
Jefferies
Buy
Maintained
71,00 $
-5,6%
04/28/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
53,00 $
-29,5%
04/14/2026
Last report
2026 ж. 28 шіл.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,30 $ / 0,28 $
+5,26%beat
Revenue / Est. (USD)
243,60 млн / 226,46 млн
+7,57%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
180,86 млн
202,13 млн
214,27 млн
243,60 млн
Cost of goods sold
83,56 млн
90,98 млн
96,37 млн
111,64 млн
Cost of revenue
83,56 млн
90,98 млн
96,37 млн
111,64 млн
Research and development expenses
24,17 млн
34,61 млн
27,48 млн
40,90 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49,10 млн
56,78 млн
61,15 млн
63,87 млн
Operating expense
73,27 млн
91,38 млн
88,63 млн
104,76 млн
Total operating expenses
156,83 млн
182,36 млн
185,00 млн
216,41 млн
Operating income
24,02 млн
19,77 млн
29,27 млн
27,19 млн
Other non operating income
3,14 млн
3,50 млн
3,41 млн
3,95 млн
EBT including unusual items
27,16 млн
23,27 млн
32,68 млн
31,14 млн
EBT excluding unusual items
27,16 млн
23,27 млн
32,68 млн
31,14 млн
Income tax expense
8,72 млн
9,07 млн
10,09 млн
5,71 млн
Effective tax rate
32,12%
38,98%
30,87%
18,34%
Other operating expenses
-
-
-
-
Net income
18,44 млн
14,20 млн
22,59 млн
25,43 млн
Net profit margin
10,19%
7,02%
10,54%
10,44%
Earnings per share
0,23
0,17
0,27
0,30
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
24,40 млн
20,24 млн
29,74 млн
27,67 млн
Gain or loss from assets sale
-43,00 мың
-53,00 мың
-54,00 мың
22,00 мың
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары